Hybaid's Dynamic Allele Specific Hybridization system Understanding the relationship between genetic variations at the nucleotide sequence level and human disease will profoundly change prevention and treatment methods in the next decade. The DNA sequence information produced through the Human Genome Project will reveal thousands of variations at single nucleotides, termed single nucleotide polymorphisms (SNPs). Such sequence variations in DNA may disrupt gene function and be causally associated
 Hybaid's Dynamic Allele Specific Hybridization system |
Hybaid (Franklin, Mass.) released its new dedicated system for SNP detection, the DASH (Dynamic Allele Specific Hybridization) system, in July 1999. It provides a fast, sensitive method to score SNPs based on the melting temperature (denaturation) of target-probe complexes. The DASH system monitors the level of fluorescence emitted from a dye intercalated into the target-probe sequences ...
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this Issue
In this webinar, Felix Lansing will discuss how AI-driven models improve recombinase development.
In this webinar, Brian Hie will discuss Evo2, a state-of-the-art genomic foundation model capable of generalist prediction and design tasks across DNA, RNA, and proteins.
In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.
In the dynamic biotechnology and biopharmaceutical science fields, qPCR and dPCR multiplexing has emerged as a crucial technique for accelerated and consistent research workflows.
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model
Zymo Research, a global leader in sample preparation technologies and sustainable life science solutions, will partner with Harvard University to host the BioFestival on October 18, 2025.
Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases
This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.
